Earnings News

Financial Results in Focus: Cellect Biotechnology Ltd. (NASDAQ:APOP)

Spread the love

Cellect Biotechnology Ltd. (NASDAQ:APOP) spotted trading -91.79% off 52-week high price. On the other end, the stock has been noted 4.36% away from the low price over the last 52-weeks. The stock changed 1.59% to recent value of $0.64. The stock transacted 39719 shares during most recent day however it has an average volume of 293.18K shares. The company has 11.2M of outstanding shares .

Cellect Biotechnology Ltd. (NASDAQ:APOP), a developer of innovative technology which enables the functional selection of stem cells, announced financial and operating results for the first quarter ended March 31, 2019.

First Quarter 2019 Financial Results:

Research and development (R&D) expenses for the first quarter of 2019 were $0.97 million, compared to $1.11 million in the fourth quarter of 2018 and $0.79 million in the first quarter of 2018. The decrease in the first quarter of 2019 as compared to the fourth quarter of 2018 was primarily due to a decrease in clinical trial activity.

General and administrative (G&A) expenses for the first quarter of 2019 were $0.65 million, compared to $1.30 million in the fourth quarter of 2018 and $0.95 million in the first quarter of 2018. The decrease in the first quarter of 2019 as compared to the fourth quarter of 2018 was primarily due to decrease in expenses related to provision for bonus for 2018 and stock-based compensation.

Finance income for the first quarter of 2019 were $0.21 million, compared to finance income of $1.38 million in the fourth quarter of 2018. The decrease was primarily due to changes related to fair value of the tradable and non-tradable warrants issued in a prior fundraising.

Net loss for the first quarter of 2019 was $1.40 million, or $0.008 per share and $0.16 per ADS, compared to $1.03 million, or $0.008 per share and $0.16 per ADS, in the fourth quarter of 2018, and $0.98 million, or $0.008 per share and $0.15 per ADS, in the first quarter of 2018.

* For the convenience of the reader, the amounts above have been translated from NIS into U.S. dollars, at the representative rate of exchange on March 31, 2019 (U.S. $1 = NIS 3.632).

The price moved ahead of -21.51% from the mean of 20 days, -30.50% from mean of 50 days SMA and performed -78.67% from mean of 200 days price. Company’s performance for the week was -9.85%, -28.07% for month and YTD performance remained -69.52%.

Leave a Reply

Your email address will not be published. Required fields are marked *